HbA1c and fasting plasma glucose levels are equally related to incident cardiovascular risk in a high CVD risk population without known diabetes

RA Been, E Noordstar, MAG Helmink, TT van Sloten… - Diagnosis, 2024 - degruyter.com
Abstract Objectives Type 2 diabetes (T2DM) is associated with increased risk for
cardiovascular disease (CVD). Whether screen-detected T2DM, based on fasting plasma …

The Value of Hemoglobin Glycation Index–Diabetes Mellitus System in Evaluating and Predicting Incident Stroke in the Chinese Population

P Wang, Q Li, X Guo, Y Zhou, Z Li, H Yang… - Journal of Clinical …, 2022 - mdpi.com
We aimed to clarify the effect of the hemoglobin glycation index (HGI)–diabetes mellitus
(DM) system in evaluating the risk of incident stroke. We followed up on 2934 subjects in …

[HTML][HTML] Effect of liraglutide combined with metformin or acarbose on glucose control in type 2 diabetes mellitus and risk factors of gastrointestinal adverse reactions

G Ren, X Ma, P Jiao - American Journal of Translational Research, 2022 - ncbi.nlm.nih.gov
Objective: To investigate the effect of liraglutide combined with metformin or acarbose on
glucose control in patients with type 2 diabetes mellitus (T2DM) and to analyze the risk …

Hemoglobin A1c and blood pressure in type2 diabetic patients

ATY Aldossary, AA Mohammed, AJ Nawfal… - Egyptian Journal of …, 2021 - journals.ekb.eg
Glycated hemoglobin (HbA1C) is a strong marker for diabetic control measurements,
reflecting average blood glucose levels over the past 3-4 months. This test is affected by …